61019-32-7

Usage

Uses

Used in Chemical Research:
2-(pyridin-4-ylcarbonyl)hydrazinecarbodithioic acid is used as a research chemical for its unique structural features and potential in various chemical reactions and synthesis processes. Its complex nature allows for exploration in different areas of chemistry, including organic synthesis and medicinal chemistry.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2-(pyridin-4-ylcarbonyl)hydrazinecarbodithioic acid is used as a precursor or intermediate in the synthesis of various pharmaceutical compounds. Its unique functional groups may contribute to the development of new drugs with specific therapeutic properties.
Used in Material Science:
2-(pyridin-4-ylcarbonyl)hydrazinecarbodithioic acid may also find applications in material science, where its chemical structure could be leveraged to create new materials with specialized properties, such as in the development of advanced polymers or coatings.

Upstream product

• 90322-87-5 1-isonicotinoyl-1H-imidazole 
• 1570-45-2 isonicotinic acid ethylester 
• 2459-09-8 4-pyridinecarboxylic acid, methyl ester 
• 55-22-1 pyridine-4-carboxylic acid 
• 75-15-0 carbon disulfide 
• 54-85-3 isoniazid 

Downstream Products

• 15264-63-8 5-(pyridin-4-yl)-1,3,4-oxadiazol-2(3H)-thione 
• 15264-63-8 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol 
• 80809-41-2 3-(4-pyridyl)-6-amino-s-triazolo<3,4-b>-1,3,4-thiadiazole 
• 1423159-83-4 2-(4-nitrobenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4yl]hydrazine carbothioamide 
• 1423159-84-5 2-(2-chlorobenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-85-6 2-(3-chlorobenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-86-7 2-(4-chlorobenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-87-8 2-(4-methoxybenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl] hydrazine carbothioamide 
• 1423159-88-9 N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]-2-(3,4,5-trimethoxybenzylidene)hydrazine carbothioamide 
• 1423159-89-0 2-(3-hydroxybenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-90-3 2-(3-hydroxy-4-methoxybenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-91-4 2-(4-fluorobenzylidene)-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 1423159-82-3 2-benzylidene-N-[3-(pyridin-4-yl)-5-sulfanyl-4H-1,2,4-triazol-4-yl]hydrazine carbothioamide 
• 143700-69-0 6-((2,4-dichlorophenoxy)methyl)-3-(pyridin-4-yl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole 

Relevant academic research and scientific papers

Synthesis and characterization of transition metal complexes of potassium 3-(pyridine-4-carbonylmethyl)-dithiocarbazate

The preparation and characterization of some dipositive metal ion complexes derived from potassium 3-(pyridine-4-carbonylmethyl)-dithiocarbazate (PCDHK) are reported. The solid complexes of the composition ML·nH2O (M=Cu(II), Co(II), Mn(II), Zn(II), Cd(II), Ni(II), Pb(II), L = PCD-2, n = 0, 1, PCD-2= PCDHK-K+-H+) and ML 2·2H2O (M=UO2(IV), L=PCDH-1, PCDH-1=PCDHK-K+) have been characterized by elemental analyses, IR, UV, and 1H NMR spectra. The IR spectral data indicate that PCDHK behaves as either a mononegative or binegative ligand and coordinates in a tridentate or bridging tetradentate manner.

Syntheses, structural and thermal studies on Zn(II) complexes of 5-aryl-1,3,4-oxadiazole-2-thione and dithiocarbamates: Antibacterial activity and DFT calculations

The new complexes [Zn(pyot)2(en)2] (1), [Zn(mphot)2(en)2] (2), [Zn(bhpzdtc)2(py)] (3), [Zn(bhpzdtc)2(4-pic)] (4) and [Zn(ecpzdtc)(bpy)(Cl)] (5) {pyot = 5-(4-pyridyl)-1,3,4-oxadiazole-2-thio

Synthesis, spectral and structural studies of a Mn(II) complex of [N′-(pyridine-4-carbonyl)-hydrazine]-carbodithioic acid ethyl ester and Mn(II) and Ni(II) complexes of [N′-(pyridine-4-carbonyl)-hydrazine]-carbodithioic acid methyl ester

The new complexes [Mn(Hpchce)2(o-phen)], {2[Mn(pchcm)(o-phen)2]}·7H2O and [Ni(Hpchcm)(o-phen)2]Cl·CH3OH with [N′-(pyridine-4-carbonyl)-hydrazine]-carbodithioic acid ethyl ester (H2pchce) and [N′-(pyridine-4-carbonyl)-hydrazine]-carbodithioic acid methyl ester (H2pchcm) have been synthesized, containing o-phenanthroline (o-phen) as a coligand. These ligands and their complexes have been characterized by elemental analyses, IR, magnetic susceptibility and single crystal X-ray data. H2pchce (2), [Mn(Hpchce)2(o-phen)] (3) {2[Mn(pchcm)(o-phen)2]}·7H2O (4) and [Ni(Hpchcm)(o-phen)2]Cl·CH3OH (5) crystallized in the monoclinic system, space group Pc, C2/c, P21/n and P21/n, respectively. The (N, O) donor sites of the bidentate ligands chelate the Mn(II) and Ni(II) centers forming a five-membered CN2OM ring. The resulting complexes are paramagnetic and have a distorted octahedral geometry.

Synthesis, structural characterization, DFT, fluorescence, and redox behaviour of 4-[5-(2-picolylsulfanyl)-1,3,4-oxadiazole-2-yl]-pyridine

The effective experimental content of this paper reports the synthesis of new 1,3,4-oxadiazole derivative 4-[5-(2-picolylsulfanyl)-1,3,4-oxadiazole-2-yl]-pyridine (pop) which was carried out in a cyclization reaction containing potassium N′-(pyridine-4-carbonyl)-hydrazinecarbodithioate in the presence of 2-picolyl chloride. The synthesized compound pop has been characterized by elemental analyses, UV–vis., Infrared, NMR, and X-ray diffraction data which crystallizes in a triclinic system having space group P-1. The dihedral angle formed between the pyridine ring and oxadiazole ring indicates that all the rings present in the compound are planar with each other. An electrochemical study shows that compound pop exhibits a reversible redox process assignable to a one-electron transfer reaction. The intermolecular C–H···N hydrogen bonding and π···π interactions provide stability to the structure of compound pop. The fingerprint plots associated with Hirshfeld surface analysis clearly shows that there are two types of weak interactions N···H–C and S···C through red spots. Fluorescence spectra of Co2+, Cr2+, Cu2+, Cd2+, Hg2+, and Zn2+ ions with pop exhibit better fluorescence whereas Mn2+ and Ni2+ ions are less fluorescent as compared to the free pop. To get a better understanding of Frontier molecular orbitals and intramolecular charge transfer property, theoretical calculations, such as density functional theory (DFT), were performed which indicates that compound pop is soft and highly reactive.

Design, synthesis, antibacterial evaluation, and computational studies of hybrid oxothiazolidin–1,2,4-triazole scaffolds

Bacterial infections are a serious threat to human health due to the development of resistance against the presently used antibiotics. The problem of growing and widespread antibiotic resistance is only getting worse with the shortage of new classes of antibiotics, creating a substantial unmet medical need in the treatment of serious bacterial infections. Therefore, in the present work, we report 18 novel hybrid thiazolidine–1,2,4-triazole derivatives as DNA gyrase inhibitors. The derivatives were synthesized by multistep organic synthesis and characterized by spectroscopic methods (1H and 13C nuclear magnetic resonance and mass spectroscopy). The derivatives were tested for DNA gyrase inhibition, and the result emphasized that the synthesized derivatives have a tendency to inhibit the function of DNA gyrase. Furthermore, the compounds were also tested for antibacterial activity against three Gram-positive (Bacillus subtilis [NCIM 2063], Bacillus cereus [NCIM 2156], Staphylococcus aureus [NCIM 2079]) and two Gram-negative (Escherichia coli [NCIM 2065], Proteus vulgaris [NCIM 2027]) bacteria. The derivatives showed a significant-to-moderate antibacterial activity with noticeable antibiofilm efficacy. Quantitative structure–activity relationship (QSAR), ADME (absorption, distribution, metabolism, elimination) calculation, molecular docking, radial distribution function, and 2D fingerprinting were also performed to elucidate fundamental structural fragments essential for their bioactivity. These studies suggest that the derivatives 10b and 10n have lead antibacterial properties with significant DNA gyrase inhibitory efficacy, and they can serve as a starting scaffold for the further development of new broad-spectrum antibacterial agents.

Synthesis and Biological Evaluation of 1,2,4-Triazole Thioethers as Both Potential Virulence Factor Inhibitors against Plant Bacterial Diseases and Agricultural Antiviral Agents against Tobacco Mosaic Virus Infections

Targeting the virulence factors of phytopathogenic bacteria is an innovative strategy for alleviating or eliminating the pathogenicity and rapid outbreak of plant microbial diseases. Therefore, several types of 1,2,4-triazole thioethers bearing an amide l

HERBICIDAL COMPOUNDS

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

Design, synthesis, biological activity, crystal structure and theoretical calculations of novel 1,2,4-triazole derivatives

Series of 1,2,4-triazole Schiff base (Ia-f) were designed and synthesized. Their in-vitro antifungal activity to pythium solani, gibberlla nicotiancola, fusarium oxysporium fs.p. niveum and gibberlla saubinetii were evaluated. The results showed compound If exhibited good activity with tested fungi, which indicated that 1,2,4-triazole scaffold with introduction of imidazole phenyl could keep the antifungal activity. In order to further research the compound If, the crystal structure was detected by X-ray diffraction. Meanwhile, the FT-IR, FT-Raman, natural bond orbital (NBO), HOMO-LUMO and MEP were calculated at B3LYP/6-311G+(d,p) level. All the results will be helpful for further drug design in 1,2,4-triazole analogues.

1,2,4-Triazole-conjugated 1,3,4-thiadiazole hybrid scaffolds: A potent ameliorant of carrageenan-induced inflammation by lessening proinflammatory mediators

Inflammation acts as an alarming signal for the progression of various biological complications. Various reports in the literature have revealed that heterocycle-containing synthetic compounds have a restorative capability against acute and chronic inflammatory stages. In the current study, we synthesized a series of 1,2,4-triazole-conjugated 1,3,4-thiadiazole hybrid scaffolds and evaluated their impacts against carrageenan-induced paw edema and proinflammatory markers in Wistar rats. Further, 3D QSAR study (three-dimensional quantitative structure–activity relationships), ADMET (absorption, distribution, metabolism, and excretion) profiling, and docking studies were performed to determine the possible mechanism of the action of the derivatives. The study shows that the most active derivatives, 13f and 13g, have optimal logP, a higher anti-inflammatory activity score, and poor metabolism at various sites of cytochrome P450. The docking studies recommended that the synthesized compounds have a similar affinity as the ligands A307, 63X, and S58 to interact with tumor necrosis factor-α, COX-1, and COX-2. So, these molecules will definitely hold a promise for the future drug development initiative.

Synthesis of some new acylhydrazone compounds containing the 1,2,4-triazole structure and their neuritogenic activities in Neuro-2a cells

In the present study, a novel series of acylhydrazone compounds (A0-A10) with the structure of 1,2,4-triazole have been designed and synthesized. In addition, all the synthesized compounds have been evaluated for neuritogenic activity in mouse neuroblastoma (Neuro-2a) cells. Notably, we found that one of these 11 acylhydrazone compounds, compoundA5(2-(4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-ylthio)-N′-(2-hydroxybenzylidene)-acetohydrazide) displays excellent neuritogenic activity. Moreover, our present study revealed that compoundA5had the ability to induce neurite outgrowth through the PI3K/Akt and MEK-ERK signaling pathway in Neuro-2a cells. These findings suggest that compoundA5might exert neuritogenic effects and thus may be useful for the treatment of neural repair and regeneration.